Gene delivery can be used to test hypothesis on brain mechanisms of alcoholism as well as providing a potential new therapeutic approach to drug abuse. Both human and animal data have implicated decreased dopamine (DA)and/or serotonin (5-hydroxytryptamine-5HT) in the nucleus accumbens (NAc) and other forebrain areas with high alcohol drinking behaviors. The hypothesis to be tested in this proposal is that viral vectors enhancing levels of the biogenic amines, DA and/or 5HT in specific brain regions will alter responses to ethanol, particularly high alcohol drinking behavior. Levels of DA and 5HT will be selectively increased in specific brain regions by constructing vectors containing synthetic enzymes using the adeno-associated virus (AAV) vector system. This approach prepares a therapeutic agent-drug that contains less than 5% of the original viral genome and the enzymes tyrosine hydroxylase (TH), aromatic amino acid decarboxylase( AADc) and tryptophan decarboxylase.( TRYPH). Preliminary studies have shown that the AAV vector is not neurotoxic and can express TH-AADC in brain to levels that raise the concentration of brain DA sufficient to partially restore motor abnormalities in models of Parkinson's disease. Expression is known to occur for at least several months in many brain regions. These preliminary studies indicate the AAV- Th-AADC vector can be used to increase DA levels in brain.
The aims of this proposal are: 1. To investigate the expression of AAV-tyrosine hydroxylase-aromatic amino acid decarboxylase (AAV-TH-AADC) vectors in various brain regions including the ventral tegmental area (VTA) , NAc, and forebrain. Variables will include vector load and brain region(s) of expression. Preliminary studies have indicated that a AAV-lacZ vector is expressed in NAc. The AAV-lacZ vector will be used to investigate specific cell sites of expression and to serve as a """"""""vehicle"""""""" control for AAV vectors containing the TH-AADC.Th-AADC expression will be determined using a FLAG epitope included in the vector for immunohistochemical distinction from endogenous enzyme, total TH immunohistochemistry, total TH activity, the content of DA and DA metabolites as well as PCR of viral DNA. 2. To determine the effects of AAV-Th-AADC vector induced increased dopamine in nucleus accumbens and/or VTA on ethanol behaviors, particularly high ethanol drinking behaviors in P and NP rats. 3. Develop an AAV-Tryptophan hydroxylase-aromatic amino acid decarboxylase vector (AAV-TRYPH-AADC) to enhance 5HT levels in NAc, VTA, Raphe, forebrain and other areas of interest. Variables will include vector load and brain region(s) of expression. 4. Determine the effects of increased 5HT synthesis in NAc, forebrain and/or Raphe on behaviors as in Specific Aim 2.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Specialized Center (P50)
Project #
5P50AA011605-03
Application #
6200917
Study Section
Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
3
Fiscal Year
2000
Total Cost
$178,517
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Jaramillo, Anel A; Randall, Patrick A; Stewart, Spencer et al. (2018) Functional role for cortical-striatal circuitry in modulating alcohol self-administration. Neuropharmacology 130:42-53
Bohnsack, John Peyton; Hughes, Benjamin A; O'Buckley, Todd K et al. (2018) Histone deacetylases mediate GABAA receptor expression, physiology, and behavioral maladaptations in rat models of alcohol dependence. Neuropsychopharmacology 43:1518-1529
Coleman Jr, Leon G; Zou, Jian; Qin, Liya et al. (2018) HMGB1/IL-1? complexes regulate neuroimmune responses in alcoholism. Brain Behav Immun 72:61-77
Coleman Jr, Leon G; Crews, Fulton T (2018) Innate Immune Signaling and Alcohol Use Disorders. Handb Exp Pharmacol 248:369-396
Harper, Kathryn M; Knapp, Darin J; Park, Meredith A et al. (2017) Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats. Psychopharmacology (Berl) 234:79-88
Crews, Fulton T; Lawrimore, Colleen J; Walter, T Jordan et al. (2017) The role of neuroimmune signaling in alcoholism. Neuropharmacology 122:56-73
Vetreno, Ryan P; Patel, Yesha; Patel, Urvi et al. (2017) Adolescent intermittent ethanol reduces serotonin expression in the adult raphe nucleus and upregulates innate immune expression that is prevented by exercise. Brain Behav Immun 60:333-345
Vetreno, Ryan P; Yaxley, Richard; Paniagua, Beatriz et al. (2017) Adult rat cortical thickness changes across age and following adolescent intermittent ethanol treatment. Addict Biol 22:712-723
Crews, Fulton T; Walter, T Jordan; Coleman Jr, Leon G et al. (2017) Toll-like receptor signaling and stages of addiction. Psychopharmacology (Berl) 234:1483-1498
Coleman Jr, Leon G; Zou, Jian; Crews, Fulton T (2017) Microglial-derived miRNA let-7 and HMGB1 contribute to ethanol-induced neurotoxicity via TLR7. J Neuroinflammation 14:22

Showing the most recent 10 out of 126 publications